Liquid Biopsy Market by Top Key Players - Biocept, Inc., Qiagen, F. Hoffmann-La Roche AG, Bio-Rad Laboratories Inc., Myriad Genetics, Janssen Diagnostics, LLC., Trovagene Inc.

Liquid biopsies are non-invasive blood tests that detect tumor DNA & RNA fragments and circulating tumor cells (CTCs), which are released into the blood from the primary tumors and metastatic sites. It is a minimally invasive technology for the detection of molecular biomarkers, excluding expensive or invasive procedures.

Get Sample Copy of this Report @ https://www.bigmarketresearch.com/request-sample/1169135?utm_source=RK&utm_medium=OPR

The Liquid Biopsy Market research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data and statistically-supported and industry-validated market data and projections with a suitable set of assumptions and methodology. It provides analysis and information by categories such as market segments, regions, and product type and distribution channels.

This report focuses on the Liquid Biopsy in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

By Market Players: Biocept, Inc., Qiagen, F. Hoffmann-La Roche AG, Bio-Rad Laboratories Inc., Myriad Genetics, Janssen Diagnostics, LLC., Trovagene Inc., Guardant Health Inc., GRAIL, MDX Health SA

Liquid biopsy is a simple and precise alternative to surgical biopsies, which allows physicians & surgeons to detect & treat cancer at an early stage and acquire tumor information through blood samples. These biopsies are particularly significant as they help the physician to understand the molecular changes and dynamics of cancer. Moreover, cancer recurrence is expected to be understood through well-timed liquid biopsies.

Surge in prevalence of cancer, advantages of liquid biopsy over solid tumor biopsy, rise in awareness about minimally invasive procedures, and favorable government initiatives supplement the market growth. However, alternatives to liquid biopsies and unclear reimbursement & regulation scenario impede the growth.

The liquid biopsy market is segmented based on product & service, cancer type, circulating biomarker, end user, and geography. Based on product & service, it is divided into reagents, instruments, and services. On the basis cancer type, it is classified into lung cancer, breast cancer, colorectal cancer, prostate cancer, liver cancer, and other cancer.

KEY MARKET BENEFITS FOR STAKEHOLDERS:
• The study provides an in-depth analysis of the global liquid biopsy market and the current trends and future estimations to elucidate the imminent investment pockets.
• The report presents quantitative analysis of the market from 2016 to 2023 to enable stakeholders to capitalize on the prevailing market opportunities.
• Extensive analysis of the market based on cancer types assists to understand the trends in the industry.
• Key market players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.

Get a discount on this research report @ https://www.bigmarketresearch.com/request-for-discount/1169135?utm_source=RK&utm_medium=OPR

Table of Content
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. TOP PLAYER POSITIONING, 2016
3.4. PORTERS FIVE FORCES ANALYSIS
3.5. REGULATIONS
3.6. MARKET DYNAMICS
3.6.1. Drivers
3.6.1.1. Increase in demand for safe and non-invasive procedures
3.6.1.2. Surge in prevalence of cancer worldwide.
3.6.1.3. Advantages of liquid biopsy tests
3.6.2. Restraints
3.6.2.1. Limitations associated with liquid biopsy testing
3.6.2.2. Lack of awareness in developing in underdeveloped regions
3.6.3. Opportunities
3.6.3.1. Rise in pre-screening programs for cancer detection using liquid biopsy
3.6.3.2. Untapped potential of emerging markets
CHAPTER 4 LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. KITS & REAGENTS
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. PLATFORMS & INSTRUMENTS
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.4. SERVICES
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
CHAPTER 5 LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. CIRCULATING TUMOR CELL (CTC)
5.2.1. Market size and forecast
5.3. CIRCULATING TUMOR DNA (CTDNA)
5.3.1. Market size and forecast
5.4. EXTRACELLULAR VESICLES (EVS)
5.4.1. Market size and forecast
5.5. OTHER BIOMARKERS
5.5.1. Market size and forecast

For More Info @: https://www.bigmarketresearch.com/purchase-enquiry/1169135?utm_source=RK&utm_medium=OPR

About Us:
Big Market Research has a range of research reports from various publishers across the world. Our database of reports of various market categories and sub-categories would help to find the exact report you may be looking for.
We are instrumental in providing quantitative and qualitative insights on your area of interest by bringing reports from various publishers at one place to save your time and money. A lot of organizations across the world are gaining profits and great benefits from information gained through reports sourced by us.

Contact Us:
5933 NE Win Sivers Drive, #205, Portland,
OR 97220 United States
call answer Direct:+1-971-202-1575
call answer Toll Free:+1-800-910-6452
email help@bigmarketresearch.com

This release was published on openPR.